Beyond the Fields: Agricultural Fungicides Drive Fungal Resistance Linking Climate, Food Chains, and Clinical Failures

The University of Manchester-led perspective in npj Antimicrobials and Resistance (Weeks et al., 2026) correctly flags dual-use azole fungicides on 94% of UK arable crops as a driver of fungal antimicrobial resistance (fAMR), yet underplays the accelerating role of climate shifts in expanding resistant Aspergillus and Candida ranges. This observational policy analysis, lacking RCT-level causal data or quantified sample sizes from longitudinal field-clinic cohorts, draws on fragmented UK surveillance rather than integrated One Health datasets. It misses documented supply-chain vulnerabilities, where wheat and maize losses from resistant pathogens could compound global shortages already projected at 10-15% under 2°C warming scenarios. Cross-referencing with Fisher et al. (Nature Reviews Microbiology, 2022 observational synthesis of 50+ studies) reveals azole-resistant A. fumigatus isolates rising from environmental hotspots to 10-15% of clinical cases in Europe, with no reported industry conflicts but reliance on passive sampling. WHO 2022 fungal priority pathogens list adds urgency, estimating 2.5 million annual deaths disproportionately in immunocompromised groups. Coordinated monitoring could preempt hospital failures while safeguarding yields; without it, medicine shortages and crop shortfalls converge faster than siloed regulators anticipate.